AstraZeneca says working with Southeast Asian nations on vaccine deliveries
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
MONDAY, MAY 23, 2022
MONDAY, MAY 23, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
AstraZeneca says working with Southeast Asian nations on vaccine deliveries

Coronavirus chronicle

Reuters
10 June, 2021, 03:10 pm
Last modified: 10 June, 2021, 03:17 pm

Related News

  • Covax calls for urgent action to close vaccine equity gap
  • Cholera inoculation in Dhaka starting first week of May
  • Corruption allegation over vaccine has no evidence: Ahmad Kaikaus
  • 23 lakh citizens to get cholera vaccine in Dhaka from May
  • Meningitis vaccine protects against gonorrhoea: Studies

AstraZeneca says working with Southeast Asian nations on vaccine deliveries

Malaysia and Taiwan this week became the latest in the region to warn they expected delays in deliveries of AstraZeneca vaccines manufactured in Thailand

Reuters
10 June, 2021, 03:10 pm
Last modified: 10 June, 2021, 03:17 pm
Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo
Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo

AstraZeneca (AZN.L) says it is working closely with Southeast Asia governments to ensure its Covid-19 vaccine is supplied "as quickly as possible", after reported delays in deliveries of orders from a Thai plant owned by the country's powerful king.

Malaysia and Taiwan this week became the latest in the region to warn they expected delays in deliveries of AstraZeneca vaccines manufactured in Thailand.

"Distribution to other Southeast Asian countries, including Malaysia, will commence in the coming weeks," the company said in an e-mail to Reuters.

"We are working closely with each of the relevant governments to supply our Covid-19 vaccine as quickly as possible," the AstraZeneca statement said.

It did not respond further to questions on the Thai plant's current and anticipated future production levels.

AstraZeneca's distribution plans in Southeast Asia depend on 200 million doses made by Siam Bioscience, a company owned by Thailand's king that is making vaccines for the first time.

Questions about Siam Bioscience meeting production targets are sensitive because King Maha Vajiralongkorn is its sole owner. Insulting Thailand's monarchy is a crime punishable by up to 15 years in prison.

Siam Bioscience in January said it had an estimated production capacity of 200 million doses per year, an average of 15-20 million doses per month. The Thai company and AstraZeneca have not revealed total production goals nor commented on whether the plant has missed its targets.

Malaysia had been due to receive 610,000 doses from Thailand in June and 1.6 million later this year, but its Science Minister Khairy Jamaluddin said on Wednesday "we are expecting some delay."

The first delivery to the Philippines, which was promised 17 million doses, was reduced and postponed by several weeks, a Philippine presidential adviser said last week.

Thailand, which expects to receive six million doses for June, last week received 1.8 million locally-produced doses and 200,000 imported from South Korea.

AstraZeneca has previously run into production and delivery problems in other parts of the world. A deal to set up production in Taiwan did not materialise and it is also facing a legal challenge by the European Union over a supply contract.

World+Biz

AstraZeneca / Southeast Asian nations / Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • BPC hunts for dollar to import fuel oil
    BPC hunts for dollar to import fuel oil
  • Representational Image. Photo: Mumit M/TBS
    Govt to list products to suspend imports amid dollar crisis
  • Infographic: TBS
    With 2 months left, 45% ADP fund still unspent 

MOST VIEWED

  • A person in personal protective equipment (PPE) walks a dog at a resident community, as the second stage of a two-stage lockdown has been launched to curb the spread of the coronavirus disease (Covid-19) in Shanghai, China April 3, 2022. REUTERS/Aly Song
    Shanghai reopens some public transport, still on high Covid alert
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Dynamic zero-Covid approach: China's choice to safeguard lives, underpin growth
  • People wearing protective face masks walk on a street, following new cases of the coronavirus disease (Covid-19), in Shanghai, China August 25, 2021. REUTERS/Aly Song
    Shanghai district to require all shops to shut, residents to stay home
  • Photo: Courtesy
    Covax calls for urgent action to close vaccine equity gap
  • Photo: BSS/AFP
    Covax calls for urgent action to close vaccine equity gap
  • Photo: Collected
    Thousands of Covid-negative Beijing residents sent to quarantine

Related News

  • Covax calls for urgent action to close vaccine equity gap
  • Cholera inoculation in Dhaka starting first week of May
  • Corruption allegation over vaccine has no evidence: Ahmad Kaikaus
  • 23 lakh citizens to get cholera vaccine in Dhaka from May
  • Meningitis vaccine protects against gonorrhoea: Studies

Features

Why everybody wants to be like TikTok

Why everybody wants to be like TikTok

11h | Panorama
Illustration: TBS

How the ban on porn sites spawned a local cybersex industry

14h | Panorama
3 best affordable sunscreens for all

3 best affordable sunscreens for all

14h | Mode
Warah uses three types of khadi material: a sheer and light one, a medium count and a thicker one.

Warah: Embroidered with culture and womanhood

17h | Mode

More Videos from TBS

Investors, public to suffer from electricity price hike

Investors, public to suffer from electricity price hike

4h | Videos
Health benefits of summer fruits

Health benefits of summer fruits

5h | Videos
The way Bangladesh saves almost extinct fish

The way Bangladesh saves almost extinct fish

5h | Videos
Padma’s Char now largest grazing-ground

Padma’s Char now largest grazing-ground

6h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

3
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

4
Bangladesh at risk of losing ownership of Banglar Samriddhi
Bangladesh

Bangladesh at risk of losing ownership of Banglar Samriddhi

5
BSEC launches probe against Abul Khayer Hero and allies
Stocks

BSEC launches probe against Abul Khayer Hero and allies

6
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab